cilengitide has been researched along with melphalan in 1 studies
Studies (cilengitide) | Trials (cilengitide) | Recent Studies (post-2010) (cilengitide) | Studies (melphalan) | Trials (melphalan) | Recent Studies (post-2010) (melphalan) |
---|---|---|---|---|---|
194 | 29 | 133 | 8,134 | 1,351 | 1,972 |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 1 (100.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
de Bruijn, EA; de Wiel-Ambagtsheer, Ga; Eggermont, AM; Goodman, SL; Grell, M; Meyring, M; Ruegg, C; Seynhaeve, AL; Ten Hagen, TL; van Tiel, ST | 1 |
1 other study(ies) available for cilengitide and melphalan
Article | Year |
---|---|
The αVβ3/αVβ5 integrin inhibitor cilengitide augments tumor response to melphalan isolated limb perfusion in a sarcoma model.
Topics: Animals; Antineoplastic Agents, Alkylating; Antineoplastic Combined Chemotherapy Protocols; Chemotherapy, Cancer, Regional Perfusion; Disease Models, Animal; Drug Synergism; Limb Salvage; Male; Melphalan; Rats; Rats, Inbred BN; Receptors, Vitronectin; Sarcoma, Experimental; Snake Venoms | 2013 |